+91-8668442535
Home / Biotechnology / Glycomics/

Glycomics/ Glycobiology Market By Product Type (Enzymes, Instruments, Kits, Reagents), By Application (Diagnostics, Drug Discovery & Development, Oncology, Immunology) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Glycomics or glycobiology is the study of the structure, function, biosynthesis, and biology of carbohydrates, often called glycans, that are widely distributed in nature. The increasing applicability of glycobiology in biotechnology and pharmaceutical industries, a growing number of biopharmaceutical industries, and rising research institutes are major factors that assist the growth of the glycobiology market globally.

The report titled "Glycomics and Glycobiology Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall glycobiology market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on product type (enzymes, instruments, and kits), application (diagnostics, drug discovery and development, oncology, immunology, and other applications), and different geographical regions. Geographically,

The global glycomics and glycobiology market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East and Africa
  • GCC
  • the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global glycomics and glycobiology markets. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive scenario of the global glycomics and glycobiology market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global glycomics and glycobiology market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global glycobiology market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on product type, the global glycomics and glycobiology market is segmented as follows:

Enzymes:

  • Glycosidases
  • Glycosyltransferases
  • Neuraminidases
  • Sialyltransferases
  • Sulfatases
  • Carbohydrate Kinases
  • Other Enzymes

Instruments

  • Antibody Arrays
  • HPLC
  • Lectin Arrays
  • MALDI-TOF
  • Mass Spectrometers
  • Other Instruments

Kits:

  • Glycan labeling kits
  • Glycan purification kits
  • Glycan Release Kits
  • Other Kits

Reagents:

  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Other Reagents

Glycomics or glycobiology is the study of the structure, function, biosynthesis, and biology of carbohydrates, often called glycans, which are widely distributed in nature. Glycomics and glycobiology are rapidly growing fields in biology with relevance to biomedicine, biotechnology, biofuels, and basic research. The growing interest in biomolecular and biomedical research in glycobiology is a prime factor driving market growth around the globe. For the purpose of this study, the glycomics and glycobiology market is segmented on the basis of product type; among the considered market segments, enzymes will show the highest growth during the forecast period due to their consumable nature and increasing use in a variety of R&D and drug discovery procedures. Enzymes are utilized as a useful tool to understand carbohydrate structure and function.

Currently, instruments hold the largest market share due to their higher costs and their primary role in the structure and function detection. It is observed that among the instrument segments, mass spectrometers are a major revenue contributor because their higher sensitivity, accuracy, and specificity fuel market growth. Furthermore, these accurate machines are coupled with advanced data analysis and fingerprinting programs that can accurately determine the structure of complex glycan molecules.

Based on application, the global glycomics and glycobiology market is segmented as follows:

  • Diagnostics
  • Drug Discovery and Development
  • Oncology
  • Immunology
  • Other Applications

Glycomics or glycobiology is the study of the structure, function, and biology of saccharides. It is a fast-emerging field of interest for biomolecular and biomedical research around the globe. The glycobiology market is growing rapidly worldwide because saccharides play a primary role in almost every aspect of cellular processes, ranging from cell-cell interactions, energy intermediates, adhesion mechanisms, growth factor signaling, blood clotting, receptor binding, regulating the activity of hormones in the blood, and directing embryonic development. It is observed that, in the base year 2016, drug discovery and development held the largest market share due to an increase in R&D activities for the development of novel therapies and a large number of unmet needs for the treatment of chronic diseases.

For the purpose of this study, the glycomics and glycobiology market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

It is observed that in the base year 2016, North America was the largest revenue contributor in the global glycomics and glycobiology market; the market growth is mainly driven by the progress of the United States. Technological advancement, higher investment in research and development activities, the presence of a large number of biotechnology, biopharmaceutical, and pharmaceutical industries, the presence of a large number of research institutes, and growing life science industries are major factors driving the glycomics and glycobiology market in North America. However, Asia Pacific will show the highest growth during the forecast period due to increasing investments in the life sciences sector and rapidly expanding biopharmaceutical industries in the region. Because of increased R&D activities and growing partnerships between key players and local manufacturers, emerging Asian countries such as China and India are expected to drive market growth. 

Frequently Asked Question:

The market for Glycomics/ Glycobiology Market is expected to reach USD$ 1,891.9 Mn in 2025

The Glycomics/ Glycobiology Market is expected to see significant CAGR growth over the coming years, at 12.4%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Agilent Technologies,Bruker Corporation,Danaher Corporation,Merck KGaA,New England Biolabs. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2017
Category:  Biotechnology
Report ID:   58656
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support